Covered recipient · General Payments record
WUU-SHYONG WU
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2022
$4,265.28
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $654.94 | 8 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $246.60 | 2 |
| Teva Pharmaceuticals USA, Inc. | $127.89 | 2 |
| Amgen Inc. | $122.83 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $119.17 | 1 |
| Otsuka America Pharmaceutical, Inc. | $21.85 | 1 |
| OPKO Pharmaceuticals, LLC | $16.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $122.83 | 08/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939846611 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 01/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915855655 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.60 | 07/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914796257 | CMS |
| Ironwood Pharmaceuticals, Inc | $119.17 | 04/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 957910353 | CMS |
| OPKO Pharmaceuticals, LLC | $16.60 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929041287 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.85 | 05/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929354263 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.06 | 03/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954910341 | CMS |
| Teva Pharmaceuticals USA, Inc. | $114.83 | 08/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954910207 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.